No Data
Sipai Health Reports Growth and Shrinking Losses in 2024 H1
SP Health (00314.HK): The revenue for the first half of the year reached 2.364 billion yuan.
On August 19, Global Healthcare Group (00314.HK) released its interim performance report. In the first half of 2024, the company continued to focus on the organic growth and operational efficiency improvement of its core business, while maintaining sustained investment in overall digitization and collaborative development. The Group persisted in advancing its development strategy and swiftly adapting to environmental changes, achieving sustained growth. During the reporting period, the Group's revenue reached RMB 2.364 billion yuan. The Group's total gross profit during the reporting period was approximately RMB 0.229 billion yuan, a year-on-year increase of approximately 5.0%, mainly due to a significant increase in gross profit of doctor research assistance business by approximately 21.6%.
SPG Health (00314) released its interim results, with a net loss of 78.202 million yuan attributable to shareholders, narrowing 15.29% year on year.
SinoMab BioScience Limited (00314) announced its interim results for the six months ended June 30, 2024, during which time the group ...
Express News | Corrected-Sipai Health Technology H1 Revenue RMB 2,363.8 Million (Corrects Amount)
Express News | Sipai Health Technology H1 Revenue RMB 38.8 Million
SIPAI HEALTH: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024
No Data
